Education
About Us
Working with TipRanks
Follow Us
STELLA PHARMA CORPORATION (JP:4888)
:4888
RESEARCH TOOLSreports
Total Valuation
STELLA PHARMA CORPORATION has a market cap or net worth of ¥13.68B. The enterprise value is ¥9.56B.
Market Cap¥13.68B
Enterprise Value¥9.56B
Share Statistics
STELLA PHARMA CORPORATION has 34,034,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding34,034,100
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
STELLA PHARMA CORPORATION’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is -1.78%.
Return on Equity (ROE)-0.04
Return on Assets (ROA)-0.03
Return on Invested Capital (ROIC)-1.78%
Return on Capital Employed (ROCE)-0.02
Revenue Per Employee21.84M
Profits Per Employee-3.20M
Employee Count44
Asset Turnover0.18
Inventory Turnover0.12
Valuation Ratios
The current PE Ratio of STELLA PHARMA CORPORATION is -90.79. STELLA PHARMA CORPORATION’s PEG ratio is 10.60.
PE Ratio-90.79
PS Ratio0.00
PB Ratio4.06
Price to Fair Value3.99
Price to FCF-13.04
Price to Operating Cash Flow-13.50
PEG Ratio10.60
Income Statement
In the last 12 months, STELLA PHARMA CORPORATION had revenue of 961.06M and earned -140.81M in profits. Earnings per share was -4.22.
Revenue961.06M
Gross Profit811.03M
Operating Income-90.25M
Pretax Income-137.87M
Net Income-140.81M
EBITDA-99.06M
Earnings Per Share (EPS)-4.22
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
STELLA PHARMA CORPORATION pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.08
52-Week Price Change2.28%
50-Day Moving Average341.84
200-Day Moving Average454.16
Relative Strength Index (RSI)65.05
Average Volume (3m)309.74K
Important Dates
STELLA PHARMA CORPORATION upcoming earnings date is May 13, 2025, TBA Not Confirmed.
Last Earnings DateFeb 12, 2025
Next Earnings DateMay 13, 2025
Ex-Dividend Date―
Financial Position
STELLA PHARMA CORPORATION as a current ratio of 13.43, with Debt / Equity ratio of 39.72%
Current Ratio13.43
Quick Ratio10.28
Debt to Market Cap0.06
Net Debt to EBITDA24.63
Interest Coverage Ratio-22.11
Taxes
In the past 12 months, STELLA PHARMA CORPORATION has paid 2.94M in taxes.
Income Tax2.94M
Effective Tax Rate-0.02
Enterprise Valuation
STELLA PHARMA CORPORATION EV to EBITDA ratio is -104.42, with an EV/FCF ratio of 75.79.
EV to Sales10.76
EV to EBITDA-104.42
EV to Free Cash Flow75.79
EV to Operating Cash Flow73.68
Balance Sheet
STELLA PHARMA CORPORATION has ¥3.45B in cash and marketable securities with ¥813.00M in debt, giving a net cash position of -¥2.64B billion.
Cash & Marketable Securities¥3.45B
Total Debt¥813.00M
Net Cash-¥2.64B
Net Cash Per Share-¥77.54
Tangible Book Value Per Share¥96.09
Margins
Gross margin is 90.34%, with operating margin of -9.39%, and net profit margin of -14.65%.
Gross Margin90.34%
Operating Margin-9.39%
Pretax Margin-14.35%
Net Profit Margin-14.65%
EBITDA Margin-10.31%
EBIT Margin-13.92%
Analyst Forecast
The average price target for STELLA PHARMA CORPORATION is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast256.62%
EPS Growth Forecast82.54%